67361-27-7 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-Phenyl-2-propynyl)-4-(3,7,11-trimethyl-2,6,10-dodecatrienyl)piperazine is used as a potential therapeutic agent due to its unique structure and the possibility of having biological activity. Its specific application reason is to be explored further through research, as it may serve as a building block for the synthesis of novel drugs or as a target for the development of new chemical entities.
Used in Drug Development:
In the field of drug development, 1-(3-Phenyl-2-propynyl)-4-(3,7,11-trimethyl-2,6,10-dodecatrienyl)piperazine is used as a compound with potential for further exploration. The reason for its use is to understand its full potential in creating new drugs or chemical entities that can address various medical conditions. Further research is necessary to determine the specific applications and effects of 1-(3-Phenyl-2-propynyl)-4-(3,7,11-trimethyl-2,6,10-dodecatrienyl)piperazine in drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 67361-27-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,3,6 and 1 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 67361-27:
(7*6)+(6*7)+(5*3)+(4*6)+(3*1)+(2*2)+(1*7)=137
137 % 10 = 7
So 67361-27-7 is a valid CAS Registry Number.
InChI:InChI=1/C28H40N2/c1-25(2)11-8-12-26(3)13-9-14-27(4)18-20-30-23-21-29(22-24-30)19-10-17-28-15-6-5-7-16-28/h5-7,11,13,15-16,18H,8-9,12,14,19-24H2,1-4H3/b26-13+,27-18+
67361-27-7Relevant academic research and scientific papers
Non anticholinergic gastric acid secretion inhibitors. New piperazine and related derivatives
Tricerri,Elitropi,Panto,et al.
, p. 555 - 562 (2007/10/08)
Some of the new piperazine derived compounds exhibited interesting gastric antisecretory properties without anticholinergic action. 1 Piperonyl 4 (3,7,11 trimethyl 2,6,10 dodecatrienyl) piperazine was the most active as an antisecretory agent in rat. Some analogous compounds, with the piperazine ring replaced by other heterocyclic or acyclic amines, were also prepared. Structure activity relationships are discussed.
